AMERICAN ASSOCIATION FOR JUSTICE for AMERICAN ASSOCIATION FOR JUSTICE

Marine/Maritime/Boating/Fisheries MAR

Lobbying with regard to liability in civil actions arising from maritime incidents generally. Lobbying with regard to changes to Oil Pollution Act to provide civil liabilty immunity for actions taken by entities acting on behalf of a responsible party in their oil spill response obligations.

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA); SENATE

Consumer Issues/Safety/Products CSP

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5651 (112th), S. 2156 (112th), H.R. 1873 (112th), H.R. 4367 (112th), H.R. 4369 (112th), S. 3187 (112th), H.R. 4384 (112th), H.R. 3646 (112th), S. 3076 (112th), S. 3204 (112th), S. 987 (112th), S. 2295 (112th), S. 1946 (112th), H.R. 3356 (112th)

Aviation/Airlines/Airports AVI

Lobbying with regard to insurance requirements for general aviation aircraft owners.

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); White House Office; SENATE; HOUSE OF REPRESENTATIVES

Transportation TRA

Lobbying with regard to minimum insurance requirements for commercial motor vehicles. Lobbying with regard to preemption of state based causes of action Lobbying with regard to changes to the Federal Motor Carrier's Complicance Safety and Accountabilty program. Lobbying with regard to the required installation and use of electronic on-board records for commercial motor vehicles generally. S.1813/H.R.4348 (Moving Ahead for Progress in the 21st Century [MAP-21]); specific interest relating to preemption of state based causes of action, changes to vehicle weight and size requirements for commercial motor vehicles, and minimum insurance requirements for commercial motor vehicles. H.R.6064 (Temporary Surface Transportation Extension Act of 2012); specific interest relating to preemption of state based causes of action, changes to vehicle weight and size requirements for commercial motor vehicles, and minimum insurance requirements for commercial motor vehicles. Lobbying with regard to limiting disclosure of information related to safety management systems.

Contacted: Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4348 (112th), S. 1813 (112th), H.R. 6064 (112th)

Health Issues HCR

S.1718/H.R.1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses. H.R.5284 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act); to amend section 1862 of the Social Security Act with respect to the application of Medicare secondary payer rules to workers' compensation settlement agreements and Medicare set-asides under such agreements.

Contacted: Health & Human Services, Dept of (HHS); SENATE; White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 1718 (112th), H.R. 1063 (112th), H.R. 5284 (112th)

Government Issues GOV

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions and impact of Class Action Fairness Act. S.3317/H.R.5978 (Equal Employment Opportunity Restoration Act); to restore the effective use of group actions for claims arising under title VII of the Civil Rights Act of 1964, title I of the Americans with Disabilities Act of 1990, title V of the Rehabilitation Act of 1973, section 1977 of the Revised Statutes, and the Genetic Information Nondiscrimination Act of 2008. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Andrew Hurwitz and Paul Watford.

Contacted: SENATE; White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3862 (112th), H.R. 966 (112th), H.R. 5978 (112th), H.R. 1996 (112th), S. 623 (112th), S. 3317 (112th), S. 1061 (112th), S. 533 (112th), H.R. 592 (112th), H.R. 2032 (112th)

Homeland Security HOM

S.813 (Cyber Security Public Awareness Act); specific interest in limitations of liability and preemption of state based causes of action. S.413 (Cybersecurity and Internet Freedom Act); specific interest in limitations of liability and preemption of state based causes of action. S.1408 (Data Breach Notification Act); specific interest in limitations of liability and preemption of state based causes of action. H.R.3523 (Cyber Intelligence Sharing and Protection Act); specific interest in limitations of liability and preemption of state based causes of action. H.R.3674 (Promoting and Enhancing Cybersecurity and Information Sharing Effectiveness Act); specific interest in limitations of liability and preemption of state based causes of action.

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; White House Office; Health & Human Services, Dept of (HHS)

Bills named: S. 413 (112th), S. 813 (112th), H.R. 3523 (112th), S. 1408 (112th), H.R. 3674 (112th)

Torts TOR

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.5652 (Sequester Replacement Reconciliation Act); specific interest in provisions setting conditions for lawsuits arising from health care liabiltiy claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 5652 (112th), S. 2264 (112th), H.R. 4345 (112th), H.R. 3627 (112th), S. 1884 (112th), H.R. 5 (112th), H.R. 3511 (112th)